The largest pharmaceutical companies have reduced payments to Russian doctors by 17%. By the end of 2023, they received 652.6 million rubles in the form of the so-called transfer of values: payment for doctors’ participation in conferences, fees for consultations, etc.
Subscribe to RB.RU on Telegram
Ten of the world’s largest pharmaceutical companies have reduced payments to Russian doctors. In 2023, the amount of payments amounted to 652.6 million rubles, which is 17% less than in 2022. RBC reported on this based on its own calculations.
Payments, the so-called transfer of values, are expressed in payments for the participation of doctors in conferences, compensation for accommodation and travel expenses, and remuneration for consultations carried out.
The calculation is based on publicly available payment data from the Association of International Pharmaceutical Manufacturers. The calculation was based on information from the ten largest pharmaceutical companies in the world: Pfizer, Bayer, Novo Nordisk and others.
Author:
Kirill Bilyk
Source: RB
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
Join our expert trading community and receive premium signals directly to your inbox. Maximize your profits with every trade!
